SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-16-078074
Filing Date
2016-08-29
Accepted
2016-08-29 17:00:59
Documents
3
Period of Report
2016-08-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ONCOCYTE CORPORATION 8-K 8-29-2016 form8k.htm 8-K 20931
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 10952
3 image00001.jpg GRAPHIC 3817
  Complete submission text file 0001140361-16-078074.txt   38504
Mailing Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502 510-521-3390
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 161858506
SIC: 2835 In Vitro & In Vivo Diagnostic Substances